The patent is about implantable medical devices . a particularly advantageous application is in th efield of bone repair
following a criticial size bone defect
the invention is particulalry useful for defects larger than 2 cm3 up to 15 cm3
Addressing target audiences and expressing needs
- Grants and Subsidies
funding and technical help to launch our future pilot clinical trial
- Public or private funding institutions
- International Organisations (ex. OECD, FAO, UN, etc.)
- Research and Technology Organisations
R&D, Technology and Innovation aspects
current: finalizing an other proof of concept in sheeps
next steps: preparation all documents and pre-industrial production for launching a pilot clinical trial
in the field of personnalized medicine
- production using low cost equipment, water-friendly environment, room temperature
- production at vicinity of the patients and hospitals
- ease of transport
replicable to other applications for bone repair, to other applications where the bioactive proteins are used (in various fields of medicine)
also possible for other bioactive proteins, and for delivery on any type of particiles or carrier
low cost process
biodegradable polymers
local production (production) using raw products from local providers
creation of jobs
benefit to patients that have no alternative solutions
- South America
- North America
- Europe
- Middle-East
